Eprozinol dihydrochloride
Code | Size | Price |
---|
TAR-T25383-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25383-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25383-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Eprozinol dihydrochloride has anti-bronchoconstrictive activity.
CAS:
27588-43-8
Formula:
C22H32Cl2N2O2
Molecular Weight:
427.41
Purity:
0.98
SMILES:
Cl.Cl.COC(CN1CCN(CCC(O)c2ccccc2)CC1)c1ccccc1
References
1. Merigot P, Garnier R, Efthymiou ML. [Convulsions with 3 antitussive substituted derivatives of piperazine (zipeprol, eprazinone, eprozinol)]. Ann Pediatr (Paris). 1985 Jun;32(6):504-6, 511. French. PubMed PMID: 4026148.
2. Labrid C, Duchene-Marullaz P, Rispat G. Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig. Pharmacology. 1981;23(1):48-55. PubMed PMID: 7312935.
3. Labrid C, Burtin C, Stoclet JC, Dureng G, Schoeffter P, Lebel B, Duchene-Marullaz P. Mechanisms of anti-bronchoconstrictive effects of eprozinol. I. In vitro studies. Pharmacology. 1981;23(1):31-47. PubMed PMID: 6171839.
4. Nicrosini F, Carpinella G. [Eprozinol treatment of chronic bronchitis with dyspnea and cough]. Bronchopneumologie. 1978 Jul-Aug;28(4):322-7. French. PubMed PMID: 756799.